Результати пошуку - Labianca, Roberto

Уточнити результати
  1. 1
    Optimizing use of opiates in the management of cancer pain

    Optimizing use of opiates in the management of cancer pain за авторством Mandalà, Mario, Moro, Cecilia, Labianca, Roberto, Cremonesi, Marco, Barni, Sandro

    Опубліковано 2006
    Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  2. 2
    Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

    Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer за авторством Heinemann, Volker, Boeck, Stefan, Hinke, Axel, Labianca, Roberto, Louvet, Christophe

    Опубліковано 2008
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  3. 3
    Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

    Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer за авторством Labianca, Alice, Bosetti, Tommaso, Indini, Alice, Negrini, Giorgia, Labianca, Roberto Francesco

    Опубліковано 2020
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  4. 4
    Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients

    Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients за авторством Apolone, Giovanni, Bertetto, Oscar, Caraceni, Augusto, Corli, Oscar, De Conno, Franco, Labianca, Roberto, Maltoni, Marco, Nicora, Mariaflavia, Torri, Valter, Zucco, Furio

    Опубліковано 2006
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  5. 5
    Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

    Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study за авторством Barni, Sandro, Labianca, Roberto, Agnelli, Giancarlo, Bonizzoni, Erminio, Verso, Melina, Mandalà, Mario, Brighenti, Matteo, Petrelli, Fausto, Bianchini, Carlo, Perrone, Tania, Gasparini, Giampietro

    Опубліковано 2011
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  6. 6
    Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

    Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial за авторством Guida, Michele, Ravaioli, Alessandra, Sileni, Vanna Chiarion, Romanini, Antonella, Labianca, Roberto, Freschi, Antonio, Brugnara, Salvatore, Casamassima, Addolorata, Lorusso, Vito, Nanni, Oriana, Ridolfi, Ruggero

    Опубліковано 2003
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  7. 7
    Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma

    Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma за авторством Mandalà, Mario, Imberti, Gian Lorenzo, Piazzalunga, Dario, Belfiglio, Maurizio, Lucisano, Giuseppe, Labianca, Roberto, Marchesi, Lorenzo, Merelli, Barbara, Robone, Silvana, Poletti, Paola, Milesi, Laura, Tondini, Carlo

    Опубліковано 2011
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  8. 8
    Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set

    Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set за авторством Hubbard, Joleen, Thomas, David M., Yothers, Greg, Green, Erin, Blanke, Charles, O'Connell, Michael J., Labianca, Roberto, Shi, Qian, Bleyer, Archie, de Gramont, Aimery, Sargent, Daniel

    Опубліковано 2012
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  9. 9
    DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

    DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy за авторством Sinicrope, Frank A., Foster, Nathan R., Thibodeau, Stephen N., Marsoni, Silvia, Monges, Genevieve, Labianca, Roberto, Yothers, Greg, Allegra, Carmen, Moore, Malcolm J., Gallinger, Steven, Sargent, Daniel J.

    Опубліковано 2011
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  10. 10
    Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant Chemotherapy

    Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant Chemotherapy за авторством Sinicrope, Frank A., Foster, Nathan R., Yothers, Greg, Benson, Al, Seitz, Jean Francois, Labianca, Roberto, Goldberg, Richard M., DeGramont, Aimery, O’Connell, Michael J., Sargent, Daniel J.

    Опубліковано 2013
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  11. 11
    The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cancer: Current Status

    The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cance... за авторством Meyerhardt, Jeffrey A., Sargent, Daniel, Paul, James, Sobrero, Alberto, André, Thierry, Shields, Anthony F., Yoshino, Takayuki, Souglakos, Ioannis, Iveson, Timothy, Labianca, Roberto, Taieb, Julien, Ohtsu, Atsushi, Grothey, Axel

    Опубліковано 2014
    Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  12. 12
    The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status

    The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy wi... за авторством André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.

    Опубліковано 2013
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  13. 13
    ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

    ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer за авторством Renfro, Lindsay A., Grothey, Axel, Xue, Yuan, Saltz, Leonard B., André, Thierry, Twelves, Chris, Labianca, Roberto, Allegra, Carmen J., Alberts, Steven R., Loprinzi, Charles L., Yothers, Greg, Sargent, Daniel J.

    Опубліковано 2014
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  14. 14
    Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis

    Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in sit... за авторством Scartozzi, Mario, Bearzi, Italo, Mandolesi, Alessandra, Pierantoni, Chiara, Loupakis, Fotios, Zaniboni, Alberto, Negri, Francesca, Quadri, Antonello, Zorzi, Fausto, Galizia, Eva, Berardi, Rossana, Biscotti, Tommasina, Labianca, Roberto, Masi, Gianluca, Falcone, Alfredo, Cascinu, Stefano

    Опубліковано 2009
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  15. 15
    Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

    Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials за авторством Sargent, Daniel, Sobrero, Alberto, Grothey, Axel, O'Connell, Michael J., Buyse, Marc, Andre, Thierry, Zheng, Yan, Green, Erin, Labianca, Roberto, O'Callaghan, Chris, Seitz, Jean Francois, Francini, Guido, Haller, Daniel, Yothers, Greg, Goldberg, Richard, de Gramont, Aimery

    Опубліковано 2009
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  16. 16
    Validity of Adjuvant! Online in Older Patients with Stage III Colon Cancer Based on 2,967 Patients from the ACCENT Database

    Validity of Adjuvant! Online in Older Patients with Stage III Colon Cancer Based on 2,967 Patients from the ACCENT Database за авторством Papamichael, Demetris, Renfro, Lindsay A., Matthaiou, Christiana, Yothers, Greg, Saltz, Leonard, Guthrie, Katherine, Van Cutsem, Eric, Schmoll, Hans-Joachim, Labianca, Roberto, André, Thierry, O’Connell, Michael, Alberts, Steven R., Haller, Daniel G., Kountourakis, Panteleimon, Sargent, Daniel J.

    Опубліковано 2016
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  17. 17
    First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial

    First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the S... за авторством Giampieri, Riccardo, Puzzoni, Marco, Daniele, Bruno, Ferrari, Daris, Lonardi, Sara, Zaniboni, Alberto, Cavanna, Luigi, Rosati, Gerardo, Pella, Nicoletta, Zampino, Maria Giulia, Sozzi, Pietro, Germano, Domenico, Zagonel, Vittorina, Codecà, Carla, Libertini, Michela, Labianca, Roberto, Cascinu, Stefano, Scartozzi, Mario

    Опубліковано 2017
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  18. 18
    Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer

    Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer за авторством Sargent, Daniel J., Marsoni, Silvia, Monges, Genevieve, Thibodeau, Stephen N., Labianca, Roberto, Hamilton, Stanley R., French, Amy J., Kabat, Brian, Foster, Nathan R., Torri, Valter, Ribic, Christine, Grothey, Axel, Moore, Malcolm, Zaniboni, Alberto, Seitz, Jean-Francois, Sinicrope, Frank, Gallinger, Steven

    Опубліковано 2010
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  19. 19
    Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

    Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phas... за авторством André, Thierry, Meyerhardt, Jeffrey, Iveson, Timothy, Sobrero, Alberto, Yoshino, Takayuki, Souglakos, Ioannis, Grothey, Axel, Niedzwiecki, Donna, Saunders, Mark, Labianca, Roberto, Yamanaka, Takeharu, Boukovinas, Ioannis, Vernerey, Dewi, Meyers, Jeffrey, Harkin, Andrea, Torri, Valter, Oki, Eiji, Georgoulias, Vassilis, Taieb, Julien, Shields, Anthony, Shi, Qian

    Опубліковано 2020
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:
  20. 20
    Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database

    Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database за авторством Cheung, Winson Y., Renfro, Lindsay A., Kerr, David, de Gramont, Aimery, Saltz, Leonard B., Grothey, Axel, Alberts, Steven R., Andre, Thierry, Guthrie, Katherine A., Labianca, Roberto, Francini, Guido, Seitz, Jean-Francois, O’Callaghan, Chris, Twelves, Chris, Van Cutsem, Eric, Haller, Daniel G., Yothers, Greg, Sargent, Daniel J.

    Опубліковано 2016
    Отримати повний текст Отримати повний текст Отримати повний текст
    Текст
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: